Ignite Creation Date:
2024-05-06 @ 1:23 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04009057
Status:
COMPLETED
Last Update Posted:
2022-05-03
First Post:
2019-07-02
Brief Title:
Effectiveness Safety Adherence and Health-related Quality of Life in HIV-1 Infected Adults Receiving Bictegravir EmtricitabineTenofovir Alafenamide BFTAF
Sponsor:
Organization:
Gilead Sciences
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
143
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 57147 |
Who Masked List: